Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Compugen Ltd.

Market Cap 188M 164M 151M 143M 266M 17.75B 268M 1.8B 699M 8.74B 706M 691M 30.36B P/E 2026 *
-6.86x
P/E 2027 * -6.96x
Enterprise Value 188M 164M 151M 143M 266M 17.75B 268M 1.8B 699M 8.74B 706M 691M 30.36B EV / Sales 2026 *
20x
EV / Sales 2027 * 11.7x
Free-Float
97.92%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Compugen Ltd.

1 day+1.01%
1 week+2.55%
Current month-23.57%
1 month-26.91%
3 months-11.45%
6 months+32.24%
Current year+31.37%
1 week 1.96
Extreme 1.96
2.12
1 month 1.95
Extreme 1.95
2.92
Current year 1.51
Extreme 1.51
3.24
1 year 1.3
Extreme 1.295
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
9.2
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 22/09/2025
Director of Finance/CFO 42 14/08/2024
Chief Operating Officer 49 31/12/2023
Director TitleAgeSince
Chairman 59 22/09/2025
Director/Board Member 59 10/06/2018
Director/Board Member 70 10/06/2018
Date Insider Type Main position Quantity % Market Cap.
04-23Fiscal year

Chief Technology Officer

6,000 0.0063%
04-23Fiscal year

Chief Executive Officer

15,000 0.0159%
04-13Fiscal year

Chief Technology Officer

6,000 0.0063%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+2.55%+21.82%+50.00% 188M
-0.34%-1.48%-12.18%-13.39% 43.44B
+3.31%+13.04%+316.43%+562.02% 33.54B
-1.70%-7.90%+8.87%-22.34% 28.48B
+2.84%+2.48%+6.32%+34.93% 29.2B
-0.57%+3.77%+12.66%+20.42% 25.34B
-0.14%+10.03% - - 14.36B
+0.68%-1.19%+54.47%+107.47% 13.05B
+0.54%-3.88%+3.69%+2.24% 12.67B
-0.26%+1.09%+105.03%+80.69% 12.28B
Average +0.24%+0.88%+57.46%+91.34% 21.26B
Weighted average by Cap. +0.13%+0.79%+65.06%+108.99%

Financials

2026 *2027 *
Net sales 9.41M 8.21M 7.57M 7.13M 13.31M 888M 13.42M 90.03M 34.95M 437M 35.33M 34.58M 1.52B 16.05M 14M 12.91M 12.15M 22.68M 1.51B 22.88M 153M 59.58M 745M 60.23M 58.94M 2.59B
Net income -27.6M -24.08M -22.2M -20.9M -39.01M -2.6B -39.34M -264M -102M -1.28B -104M -101M -4.45B -28.01M -24.44M -22.53M -21.21M -39.59M -2.64B -39.93M -268M -104M -1.3B -105M -103M -4.52B
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
18/06/26 2.010 $ +1.01% 503,826
17/06/26 1.990 $ -1.97% 275,729
16/06/26 2.030 $ +0.50% 346,043
15/06/26 2.020 $ -0.98% 288,554
12/06/26 2.040 $ 0.00% 206,978
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.010USD
Average target price
4.600USD
Spread / Average Target
+128.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!